Ngan, Hoi-Lam
Law, Chun-Ho
Choi, Yannie Chung Yan
Chan, Jenny Yu-Sum
Lui, Vivian Wai Yan
Article History
Received: 1 June 2021
Accepted: 15 February 2022
First Online: 16 March 2022
Competing interests
: For funding unrelated to this study, VWYL served as a consultant for Novartis Pharmaceuticals (HK) Ltd. in 2015-2016. V.W.Y.L. and H.N. have a US patent pending on <i>MAPK1</i> mutations. All other authors have no direct conflicts of interest for this manuscript.